168 related articles for article (PubMed ID: 36913073)
1. First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female.
Pena-Burgos EM; De Sabando DP; Utrilla C; Pozo-Kreilinger JJ; Sastre A; Rubio P; Escudero A; Mendiola-Sabio M; Pérez-Martínez A
Head Neck Pathol; 2023 Sep; 17(3):855-863. PubMed ID: 36913073
[TBL] [Abstract][Full Text] [Related]
2. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
[TBL] [Abstract][Full Text] [Related]
3. Ectomesenchymoma with embryonal rhabdomyosarcoma and ganglioneuroma, arising in association with benign triton tumor of the tongue.
VandenHeuvel KA; Carpentieri DF; Chen J; Fung KM; Parham DM
Pediatr Dev Pathol; 2014; 17(3):226-30. PubMed ID: 24650353
[TBL] [Abstract][Full Text] [Related]
4. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
5. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Rekhi B; Upadhyay P; Ramteke MP; Dutt A
Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
[TBL] [Abstract][Full Text] [Related]
6. Malignant Ectomesenchymoma: Series Analysis of a Histologically and Genetically Heterogeneous Tumor.
Griffin BB; Chou PM; George D; Jennings LJ; Arva NC
Int J Surg Pathol; 2018 May; 26(3):200-212. PubMed ID: 28994342
[TBL] [Abstract][Full Text] [Related]
7. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
9. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.
Huang SC; Alaggio R; Sung YS; Chen CL; Zhang L; Kao YC; Agaram NP; Wexler LH; Antonescu CR
Am J Surg Pathol; 2016 Jul; 40(7):876-85. PubMed ID: 26872011
[TBL] [Abstract][Full Text] [Related]
10. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
Hornick JL; Nielsen GP
Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
[TBL] [Abstract][Full Text] [Related]
11. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
12. Malignant ectomesenchymoma of the nose. Case report and review of the literature.
Brehmer D; Overhoff HM; Marx A
ORL J Otorhinolaryngol Relat Spec; 2003; 65(1):52-6. PubMed ID: 12624508
[TBL] [Abstract][Full Text] [Related]
13. A MYOD1 mutation cooperates with PI3K pathway activation in ERMS.
Cancer Discov; 2014 Jul; 4(7):OF19. PubMed ID: 25002625
[TBL] [Abstract][Full Text] [Related]
14. More Than Meets the Eye? A Cautionary Tale of Malignant Ectomesenchymoma Treated as Low-risk Orbital Rhabdomyosarcoma.
Rashid T; Bagatell R; Pawel B; Bentley RC; Kreissman SG; Deel MD
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e854-e858. PubMed ID: 32769567
[TBL] [Abstract][Full Text] [Related]
15. [Pelvic malignant ectomesenchymoma: a case report].
Paramelle O; Croué A; Dupré F; Rialland X; Saint-André JP
Ann Pathol; 2001 Aug; 21(4):344-7. PubMed ID: 11685134
[TBL] [Abstract][Full Text] [Related]
16. A case of primary spindle cell variant of embryonal rhabdomyosarcoma of the prostate.
Asahina M; Saito T; Arakawa A; Suehara Y; Takagi T; Hisasue S; Kaneko K; Horie S; Yao T
Int J Clin Exp Pathol; 2014; 7(8):5181-5. PubMed ID: 25197394
[TBL] [Abstract][Full Text] [Related]
17. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
18. DICER1-mutated rhabdomyosarcoma of the ovary with teratoid features.
Lethongsavarn V; Vieille P; Kikweta Makhama J; Azmani R; Lafrance W; Khneisser P; Truffaut N; Alame M; Genestie C; Gaspar N; Diedhiou A; Croce S; Le Loarer F
Genes Chromosomes Cancer; 2023 Dec; 62(12):746-754. PubMed ID: 37706559
[TBL] [Abstract][Full Text] [Related]
19. Functional impact and targetability of
Choo F; Odintsov I; Nusser K; Nicholson KS; Davis L; Corless CL; Stork L; Somwar R; Ladanyi M; Davis JL; Davare MA
Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 35012940
[TBL] [Abstract][Full Text] [Related]
20. [Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway].
Orbach D
Bull Cancer; 2014 Sep; 101(9):776-7. PubMed ID: 25295632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
